These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 21621740
1. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells. Yuan X, Liu N. J Genet Genomics; 2011 May 20; 38(5):193-200. PubMed ID: 21621740 [Abstract] [Full Text] [Related]
4. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway. Yang Q, Chen C, Wu S, Zhang Y, Mao X, Wang W. Eur J Pharmacol; 2010 Dec 15; 649(1-3):108-14. PubMed ID: 20863825 [Abstract] [Full Text] [Related]
7. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Chen Y, Budd RC, Kelm RJ, Sobel BE, Schneider DJ. Arterioscler Thromb Vasc Biol; 2006 Aug 15; 26(8):1777-83. PubMed ID: 16709941 [Abstract] [Full Text] [Related]
8. [Role of peroxisome proliferators activated receptor gamma in mediating proliferation of rat vascular smooth muscle cells induced by advanced glycation end products]. Yuan XC, Liu NF, Yan JC, Zhang X. Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct 15; 33(10):940-4. PubMed ID: 16266488 [Abstract] [Full Text] [Related]
14. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway. Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, Zhao XY, Liu J, Qin ZH. Neuroscience; 2011 Mar 10; 176():381-95. PubMed ID: 21185913 [Abstract] [Full Text] [Related]